Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 4 of the 25 sources its claims cite were checked for support.
Abstract
Context: Inactivating mutations in the enzyme hexose-6-phosphate dehydrogenase (H6PDH, encoded by H6PD) cause apparent cortisone reductase deficiency (ACRD). H6PDH generates cofactor NADPH for 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1, encoded by HSD11B1) oxo-reductase activity, converting cortisone to cortisol. Inactivating mutations in HSD11B1 cause true cortisone reductase deficiency (CRD). Both ACRD and CRD present with hypothalamic-pituitary-adrenal (HPA) axis activation and adrenal hyperandrogenism. Objective: To describe the clinical, biochemical and molecular characteristics of two additional female children with ACRD and to illustrate the diagnostic value of urinary steroid profiling in identifying and differentiating a total of six ACRD and four CRD cases. Design: Clinical, biochemical and genetic assessment of two female patients presenting during childhood. In addition, results of urinary steroid profiling in a total of ten ACRD/CRD patients were compared to identify distinguishing characteristics. Results: Case 1 was compound heterozygous for R109A fsX3 and a novel P146L missense mutation in H6PD. Case 2 was compound heterozygous for novel nonsense mutations Q325X and Y446X in H6PD. Mutant expression studies confirmed loss of H6PDH activity in both cases. Urinary steroid metabolite profiling by gas chromatography/mass spectrometry suggested ACRD in both cases. In addition, we were able to establish a steroid metabolite signature differentiating ACRD and CRD, providing a basis for genetic diagnosis and future individualised management. Conclusions: Steroid profile analysis of a 24-h urine collection provides a diagnostic method for discriminating between ACRD and CRD. This will provide a useful tool in stratifying unresolved adrenal hyperandrogenism in children with premature adrenarche and adult females with polycystic ovary syndrome (PCOS).
Overview
CoChat Summary
TL;DR
This paper reports two girls with premature adrenarche who were diagnosed with apparent cortisone reductase deficiency (ACRD) caused by novel H6PD mutations, confirmed by urinary steroid profiling and functional enzyme studies. The authors argue that GC/MS urinary steroid ratios can distinguish ACRD from true cortisone reductase deficiency (CRD) and guide treatment.
Key findings
- Both girls had a urinary steroid pattern consistent with impaired cortisone-to-cortisol conversion: cortisol metabolites were low/low-normal, cortisone metabolites were elevated, and THF+5α-THF/THE and cortols/cortolones ratios were “grossly abnormal,” falling to near zero and well below the normal reference range.
- The two cases had elevated adrenal androgen output: total androgen excretion was increased, with raised metabolites of androsterone (An), etiocholanolone (Et), and DHEA.
- Case 1 was compound heterozygous for c.325delC (p.R109AfsX3) and a novel c.437C>T (p.P146L) mutation; Case 2 was compound heterozygous for c.973C>T (p.Q325X) and c.1338C>G (p.Y446X).
- In HEK293 cells, all three mutant H6PDH constructs had enzyme activity indistinguishable from mock-transfected controls, showing the mutations were inactivating; the p.P146L protein was produced at a similar level to wild type, while p.Q325X and p.Y446X were not detected by the antibody used.
Methods
- Clinical study of two female children with premature pubarche/adrenarche, with endocrine evaluation, bone age assessment, and exclusion of central precocious puberty and congenital adrenal hyperplasia.
- 24-h urinary steroid profiling by GC/MS-SIM was performed and compared with profiles from previously described ACRD/CRD cases and age-matched healthy reference cohorts.
- Genetic sequencing of HSD11B1 and H6PD was done, and mutant H6PD constructs were functionally tested in HEK293 cells by enzyme assay, RT-PCR, and Western blotting.
Limitations
- The paper states that standard plasma steroid hormone testing cannot diagnose CRD or ACRD, so urinary GC/MS is needed instead.
- The text makes evident that this is a small case series (two new patients), so the findings are descriptive and not a population-level estimate of prevalence or test performance.
- The authors note that the basis for altered 5α/5β-reductase activity in some ACRD cases is unknown.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
3 Valid · 1 Not valid · 8 Not checked · 46 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“By contrast, ACRD is caused by mutations in the H6PD gene, which encodes the enzyme hexose-6-phosphate dehydrogenase (H6PDH).”
What the sources say
- Supportedcites [4] source
The Abstract concludes that cortisone reductase deficiency (CRD) is caused by inactivating H6PD mutations. The Molecular analysis section identifies those mutations in affected patients, and the paper identifies H6PDH as hexose-6-phosphate dehydrogenase. The paper uses CRD rather than ACRD, but the claimed condition and mechanism match. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In the ER, lumen H6PDH generates cofactor NADPH that is utilised by 11β-HSD1 for the conversion of cortisone to cortisol (4) .”
What the sources say
- Supportedcites [4] source
The Fig. 1 legend (p. of FIG. 1 block) states that G6P entering the endoplasmic reticulum (ER) lumen is metabolized to 6-phosphogluconate by H6PDH, 'and, in doing so, generates NADPH, allowing 11beta-HSD1 reductase activity to convert inactive cortisone to active cortisol.' The Abstract/introduction passage likewise states that 11beta-HSD1's cortisol-regenerating reductase activity 'is critically dependent upon the provision of reduced nicotinamide adenine dinucleotide phosphate (NADPH) in the endoplasmic reticulum lumen and is provided by the enzyme hexose-6-phosphate dehydrogenase (H6PDH).' Both location (ER lumen), cofactor (NADPH), donor enzyme (H6PDH) and the cortisone-to-cortisol direction are covered. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Circulating serum androgens are elevated in all cases, so we examined the urine androgen metabolite profile also.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As a consequence of the increased cortisol clearance, total glucocorticoid output is elevated in both cases above the normal reference range ( Table 1 ).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This also results in increased ACTH-mediated adrenal androgen output reflected in elevated levels of the androgen metabolites (An, Et and DHEA) in both cases ( Table 1 ).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
15 more claims
Create a free account to see all 58 claims and to verify the 21 references still open.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 30
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Global 5α-reductase activity based on 5α-reduced over 5β-reduced THF is increased in most ACRD cases, but normal in CRD (95).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [95]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Total androgen metabolite excretion is increased; however, a distinction between CRD and ACRD based on androgen metabolites is not possible, although there is a tendency toward higher androgen output in CRD (95).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [95]
In the citing paper
“Detailed analysis of CRD and ACRD cases suggest that the (5α-THF+THF)/THE ratio and the cortols/cortolones ratio may be used to distinguish the two conditions (≤0.1 for ACRD but 0.1 to 0.5 in CRD) (95).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [95]
In the citing paper
“Total androgen metabolite excretion is increased; however, a distinction between CRD and ACRD based on androgen metabolites is not possible, although there is a tendency toward higher androgen output in CRD (95).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [95]
In the citing paper
“Urine steroid profiling reveals distinct alterations in glucocorticoid metabolism accompanied by an overall increase of androgen excretion rates (90, 92, 95).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“the 5α/5β-reductases (THF/5α-THF).”
“The 5α-THF/THF ratio is a marker of 5α/5β-reductase activity”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“a previously identified, paternally inherited c.325delC mutation resulting in a frameshift”
“a previously described cytosine insertion into exon 2 causing a frameshift”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“lifetime loss of 11β-HSD1-mediated clearance of cortisol to cortisone”
“increased activity of the 11β-HSD1 dehydrogenase reaction, converting cortisol to cortisone”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“with an exaggerated response 60 min after cosyntropin stimulation (1.336 nmol/l; NR>550 nmol/l).”
“0900 h baseline cortisol was 90.2 nmol/l”
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citationUrine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1565 · Cited by 458
Self-citationKrone, N., Hughes, B. A., Lavery, G. G., Stewart, P. M., Arlt, W., & Shackleton, C. H. L. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.04.010 · Cited by 434
Self-citationDraper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
Self-citationLavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512635200 · Cited by 207
Self-citationKotaka, M., Gover, S., Vandeputte-Rutten, L., Au, S. W. N., Lam, V. M. S., & Adams, M. J. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905002350 · Cited by 176
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163
Self-citationPremature adrenarche: novel lessons from early onset androgen excess
Idkowiak, J., Lavery, G. G., Dhir, V., Barrett, T. G., Stewart, P. M., Krone, N., & Arlt, W. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0223 · Cited by 158
Self-citationMonder, C., Shackleton, C. H. L., Bradlow, H. L., New, M. I., Stoner, E., Iohan, F., & Lakshmi, V. M. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-550 · Cited by 145
Self-citation
Cited by
Premature Adrenarche - A Common Condition with Variable Presentation
Utriainen, P., Laakso, S., Liimatta, J., Jääskeläinen, J., & Voutilainen, R. (2015) · Hormone Research in Paediatrics · doi:10.1159/000369458 · Cited by 473
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
Self-citationTreating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. W. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 209
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Self-citationNormal and Premature Adrenarche
Rosenfield, R. L. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab009 · Cited by 187
Metadata
- Authors
- Lavery, G. G., Idkowiak, J., Sherlock, M., Bujalska, I., Ride, J. P., Saqib, K., Hartmann, M. F., Hughes, B., Wudy, S. A., De Schepper, J., Arlt, W., Krone, N., Shackleton, C. H., Walker, E. A., & Stewart, P. M.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Stewart, P M
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02
- Volume
- 168
- Issue
- 2
- Pages
- K19-K26
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- PMC
- PMC3547489
- OpenAlex
- W2127065795
- Cited by
- 50
- References
- 21
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 2 · 2021: 6 · 2020: 2 · 2019: 8 · 2018: 3 · 2017: 2 · 2015: 8 · 2014: 6 · 2013: 4
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- European Journal of Endocrinology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Wellcome Trust (082809)
- National Institute for Health and Care Research (NF-SI-0508-10356)
- Medical Research Council (G1001964)
- Biotechnology and Biological Sciences Research Council (BB/G023468/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- hexose-6-phosphate dehydrogenase, urinary steroid profiling, adrenal hyperandrogenism, premature adrenarche, 11β-hydroxysteroid dehydrogenase type 1, NADPH, compound heterozygosity, polycystic ovary syndrome, 24-hour urine collection, genetic diagnosis
- MeSH terms
- Adolescent, Adult, Carbohydrate Dehydrogenases, Child, Child, Preschool, Diagnosis, Differential, Female, Hirsutism, Humans, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Steroids, 11-beta-Hydroxysteroid Dehydrogenases, Steroid Metabolism, Inborn Errors, Adrenarche, 46, XX Disorders of Sex Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling. https://app.cochat.ai/papers/10.1530/eje-12-0628
- The paper
- Lavery, G. G., Idkowiak, J., Sherlock, M., Bujalska, I., Ride, J. P., Saqib, K., Hartmann, M. F., Hughes, B., Wudy, S. A., De Schepper, J., Arlt, W., Krone, N., Shackleton, C. H., Walker, E. A., & Stewart, P. M. (2013). Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling. European Journal of Endocrinology. https://doi.org/10.1530/eje-12-0628
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.